ArrowMark Colorado Holdings LLC increased its position in Envista Holdings Co. (NYSE:NVST - Free Report) by 125.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 521,643 shares of the company's stock after acquiring an additional 290,643 shares during the period. ArrowMark Colorado Holdings LLC owned about 0.30% of Envista worth $10,062,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of NVST. Franklin Resources Inc. increased its stake in shares of Envista by 26.5% in the third quarter. Franklin Resources Inc. now owns 3,971,662 shares of the company's stock worth $78,480,000 after purchasing an additional 830,861 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Envista by 30.5% in the fourth quarter. GAMMA Investing LLC now owns 2,304 shares of the company's stock valued at $44,000 after acquiring an additional 538 shares during the period. First Hawaiian Bank lifted its stake in shares of Envista by 19.9% during the 4th quarter. First Hawaiian Bank now owns 32,285 shares of the company's stock worth $623,000 after acquiring an additional 5,363 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. bought a new position in Envista in the 4th quarter worth about $53,000. Finally, Profit Investment Management LLC raised its holdings in shares of Envista by 6.0% in the fourth quarter. Profit Investment Management LLC now owns 127,597 shares of the company's stock valued at $2,461,000 after acquiring an additional 7,226 shares in the last quarter.
Envista Stock Performance
Shares of Envista stock traded up $0.45 during trading on Wednesday, hitting $16.84. 2,322,676 shares of the stock were exchanged, compared to its average volume of 2,528,385. The stock has a market capitalization of $2.85 billion, a price-to-earnings ratio of -2.59, a price-to-earnings-growth ratio of 1.27 and a beta of 0.97. The company has a current ratio of 2.04, a quick ratio of 1.76 and a debt-to-equity ratio of 0.44. The company has a fifty day moving average price of $16.59 and a 200-day moving average price of $19.03. Envista Holdings Co. has a 1-year low of $14.22 and a 1-year high of $23.00.
Envista (NYSE:NVST - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported $0.24 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.04. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. The firm had revenue of $616.90 million for the quarter, compared to analyst estimates of $608.17 million. During the same quarter last year, the business posted $0.26 earnings per share. The company's quarterly revenue was down 1.1% on a year-over-year basis. As a group, equities analysts predict that Envista Holdings Co. will post 1 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on NVST. Robert W. Baird set a $21.00 price objective on shares of Envista in a report on Friday, May 2nd. JPMorgan Chase & Co. reduced their target price on shares of Envista from $20.00 to $19.00 and set a "neutral" rating on the stock in a research note on Thursday, March 6th. Piper Sandler dropped their target price on Envista from $18.00 to $17.00 and set a "neutral" rating for the company in a research report on Wednesday, April 30th. Wells Fargo & Company set a $19.00 price target on Envista in a report on Saturday, March 8th. Finally, New Street Research set a $19.00 price target on Envista in a report on Thursday, March 6th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $20.08.
Get Our Latest Stock Report on NVST
Envista Profile
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Stories

Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.